Lv5
1350 积分 2025-08-11 加入
ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours
14天前
已完结
[Cancer incidence and mortality across diverse geographical regions in China, 2024]
1个月前
已完结
Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries
1个月前
已完结
Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem
1个月前
已完结
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2个月前
已完结
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial
2个月前
已完结
Preoperative Predictors of Early Recurrence After Liver Resection for Multifocal Hepatocellular Carcinoma
3个月前
已完结
Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis
3个月前
已完结
A meta-analysis of prognostic factors for early recurrence in perihilar cholangiocarcinoma after curative-intent resection
3个月前
已完结
Prognostic factors for resected cases with gallbladder carcinoma: a systematic review and meta-analysis
3个月前
已完结
皖公网安备34019202002308
